Oftared Logo Banner enfermedades oculares

Publicaciones volver

Ten-year follow-up of excimer laser surface ablation for myopia in thin corneas.

Tipo: Artículo
Autores: de Benito-Llopis L, Alió JL, Ortiz D, Teus MA, Artola A.
Títuto Revista: American journal Ophthalmology.
Centro: 14 - IOA - UMH
Am J Ophthalmol. 2009 May;147(5):768-73, 773.e1-2. Epub 2009 Feb 25.

Ten-year follow-up of excimer laser surface ablation for myopia in thin corneas.


Vissum Madrid, Madrid, Spain. lbenito@vissum.com


PURPOSE: To evaluate the long-term outcomes of excimer laser surface ablation performed on thin corneas.

DESIGN: Retrospective study.

METHODS: We included in the study 75 eyes (49 patients) with a preoperative central corneal thickness (CCT) thinner than 500 mum that had undergone surface ablation to correct their myopia and that had at least 10 years of follow-up. We evaluated the stability of visual acuity (VA) and refraction, the predictability, corneal keratometry, safety, efficacy, and postoperative complications at the examinations 3 months and 1, 2, 5, and 10 years after surgery.

RESULTS: Preoperative CCT was 481.54 +/- 15.7 microm (range, 438 to 499 microm). Preoperative spherical equivalent was -6.12 +/- 2.67 diopters (D) (range, -2 to -14 D). The best spectacle-corrected VA significantly improved (P < .01) during the follow-up. The uncorrected VA showed significant improvement in all visits when compared with the 3-month postoperative visit. Both the sphere and cylinder showed a slight but significant regression (P < .01) only in the comparison between 3 months and 10 years after the surgery. Ten years after the surgery, 30 eyes (40%) were within 0.50 D and 43 eyes (57.33%) were within 1.00 D of emmetropia. The safety index improved over the 10 year period and was always higher than 0.9. The efficacy index remained stable around 0.8. The topography did not show signs of corneal ectasia and the keratometry showed no increase in corneal power. Thirty eyes (40%) needed enhancement.

CONCLUSION: Surface ablation seems to be safe and effective to correct myopia in corneas thinner than 500 microm, with stable visual and refractive outcomes in a 10-year follow-up.

PMID: 19243737 [PubMed - indexed for MEDLINE]